Melanotan I is a melanocortin agonist; the approved form treats a rare light-sensitivity disorder. It is researched most often for Skin pigmentation, Photoprotection and EPP (approved use). Approved (as afamelanotide) for a specific rare condition. This guide walks through what Melanotan I is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is Melanotan I?
Melanotan I is a melanocortin agonist that stimulates melanin production. Its clinically developed form, afamelanotide (Scenesse), is approved to reduce phototoxicity in people with erythropoietic protoporphyria (EPP).
Also known as: MT-1, Afamelanotide, Scenesse.
How does Melanotan I work?
Melanotan I is a melanocortin agonist that stimulates melanin production. Its clinically developed form, afamelanotide (Scenesse), is approved to reduce phototoxic reactions in people with erythropoietic protoporphyria (EPP) by increasing protective pigmentation.
What is Melanotan I researched for?
In the research and community discussion, Melanotan I comes up most often in connection with Skin pigmentation, Photoprotection and EPP (approved use). Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Skin pigmentation
- Photoprotection
- EPP (approved use)
What does the research actually show?
Approved (as afamelanotide) for a specific rare condition. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting Melanotan I as a guaranteed treatment is getting ahead of the evidence.
Safety and considerations
The approved form is prescription-only for EPP. Unregulated tanning use is not medically endorsed. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about Melanotan I
To go deeper, see the Melanotan I library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where Melanotan I might fit your goals.
Frequently asked questions
As afamelanotide (Scenesse), it is approved to reduce phototoxicity in people with erythropoietic protoporphyria (EPP).
No. Melanotan I has an approved clinical form for a specific condition; Melanotan II is broader-acting and not approved.
The approved form is prescription-only for EPP. Unregulated cosmetic use is not medically endorsed.
Not sure if Melanotan I fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.